| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.940682 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240830154509 |
|---|
| 006 | m o d f |
|---|
| 007 | cr |n||||||||| |
|---|
| 008 | 240717t20242024onc ob f00| 0 eng d |
|---|
| 020 | |a9780660728230 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-379/2024E-PDF |
|---|
| 245 | 00|aGuidance document : |bswitching from prescription to non-prescription status. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2024. |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (64 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Lignes directrices : changement de statut de vente de « sur ordonnance » à « sans ordonnance ». |
|---|
| 500 | |a"Date adopted: 2014-05-07. Revised date: 2024-08-14. Effective date: 2024-10-13." |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 650 | 0|aDrugs|xGovernment policy|zCanada. |
|---|
| 650 | 0|aDrugs, Nonprescription|xGovernment policy|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tLignes directrices : |w(CaOODSP)9.940683 |
|---|
| 856 | 40|qPDF|s911 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H164-379-2024-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/switching-prescription-non-prescription-status.html |
|---|
| 986 | |a240377 |
|---|